Organization
Oncode Institute
4 abstracts
Abstract
Blood based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer: The IOpener study.Org: Radbound University Medical Center, Elisabeth Tweesteden Hospital, Diakonessenhuis, PamGene International B.V., Amsterdam Medical Center,
Abstract
DIRECT2: A randomized phase III trial with a fasting mimicking diet program to improve chemotherapy in patients with hormone receptor positive, HER2-negative breast cancer—A Dutch Breast Cancer Research Group study (BOOG).Org: Leiden University Medical Center, Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, China,
Abstract
Find: Immunomodulation after a fasting mimicking diet analyzed by Nanostring and multispectral flowcytometry in healthy volunteers: A pilot study.Org: Leiden University Medical Center, Leiden University, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Oncode Institute,
Abstract
AUTOANTIBODY-POSITIVITY BEFORE TREATMENT IS ASSOCIATED WITH IMMUNE-RELATED ADVERSE EVENTS IN MELANOMA PATIENTS TREATED WITH ANTI-PD-1Org: Leiden University Medical Center, Netherlands Cancer Institute, Sanquin Diagnostic Services, Amsterdam, Netherlands, Oncode Institute, Antoni van Leeuwenhoek,